XERS
Xeris Biopharma Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$8.51
−0.99%Forward multiples
Based on analyst estimates
- P/E forward
- 44.18x
- P/E 2026E
- —
- P/E 2027E
- 24.49x
- P/E 2028E
- 14.81x
- P/S forward
- 3.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -159.30x
- Price / sales
- 4.62x
- Price / cash flow
- 27.39x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 5.12x
- EV / EBITDA
- 104.69x
- EV / EBIT
- 46.96x
- Market cap
- $1.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026